Boston Scientific (BSX) EBITDA margin US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
EBITDA margin, % | ? | 19.4% | 18.5% | 23.4% | 22.1% | 25.4% | 24.6% | ||
Changes by years, y/y, % | -5pp | -1pp | +5pp | -1pp | +3pp | +0.7% |
Boston Scientific. EBITDA margin, %
Boston Scientific. EBITDA margin, changes, pp
Boston Scientific (BSX) EBITDA margin US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
EBITDA margin, % | ? | 22.0% | 22.2% | 22.7% | 27.3% | 26.0% | 24.6% | |
Changes by years, y/y, % | +1pp | +0pp | +2pp | +3pp | +4pp | |||
Changes by quarters, q/q, % | -2pp | +0pp | +1pp | +5pp | -1pp |